Showing results (61-70 of 103) with videos related to
Sort By:
Pageof 11
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease courseS M Lippman, C M Spier, T P Miller, et al.Neurobiology of Aging|January 1, 1985
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementiaC A Peabody, S Thiemann, R Pigache, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamilT P Miller, T M Grogan, W S Dalton, et al.The American Journal of Pathology|October 1, 1988
The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphomaC M Spier, T M Grogan, S M Lippman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group studyJ K Weick, S Dahlberg, R I Fisher, et al.Blood|July 1, 1991
Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizerS E Salmon, W S Dalton, T M Grogan, et al.Anti-Cancer Drugs|December 29, 2000
Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trialC W Taylor, M LeBlanc, R I Fisher, et al.Seminars in Hematology|April 1, 1988
Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomasT P Miller, B W Dana, J K Weick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group studyT P Miller, S Dahlberg, J K Weick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group studyT P Miller, S Dahlberg, S E Salmon, et al.Pageof 11